Detalles de la búsqueda
1.
Outcomes Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy with and without Diaphragmatic Resection in Patients with Peritoneal Metastases.
Ann Surg Oncol
; 29(2): 873-882, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34546479
2.
Iterative Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Adenocarcinoma of the Appendix.
Ann Surg Oncol
; 29(6): 3390-3401, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35133518
3.
Outcomes for Elderly Ovarian Cancer Patients Treated with Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC).
Ann Surg Oncol
; 28(8): 4655-4666, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33393042
4.
Surgical and oncological outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a nonacademic center: 25-year experience.
J Surg Oncol
; 123(4): 1030-1044, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33524164
5.
Predicting Aborted Hyperthermic Intraperitoneal Chemotherapy (AHIPEC) with Preoperative Tumor and Inflammatory Markers in Potentially Resectable Appendiceal Cancer Patients with Peritoneal Carcinomatosis.
Ann Surg Oncol
; 27(7): 2548-2556, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31980984
6.
Impact of Mucin Cellularity and Distribution on Survival in Newly Diagnosed Patients with Low-Grade Appendiceal Mucinous Neoplasm Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Ann Surg Oncol
; 27(13): 4908-4917, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32409962
7.
Outcomes in Peritoneal Carcinomatosis from Appendiceal Goblet Cell Carcinoma Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC).
Ann Surg Oncol
; 27(1): 179-187, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31646450
8.
Defining "Complete Cytoreduction" After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) for the Histopathologic Spectrum of Appendiceal Carcinomatosis.
Ann Surg Oncol
; 27(13): 5026-5036, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32705513
9.
Selection and Characteristics of Patients with Peritoneal Dissemination from Appendiceal Cancer with Exceptional/Poor Survival After CRS/HIPEC.
Ann Surg Oncol
; 26(7): 2268-2275, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31041628
10.
Outcomes in Peritoneal Dissemination from Signet Ring Cell Carcinoma of the Appendix Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Ann Surg Oncol
; 26(2): 473-481, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30523470
11.
Efficacy of Hyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery in the Treatment of Recurrent Uterine Sarcoma.
Int J Gynecol Cancer
; 28(6): 1130-1137, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29975291
12.
ASO Author Reflections: What to Expect After You Resect Diaphragm During CRS/HIPEC.
Ann Surg Oncol
; 29(2): 883-884, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34537898
13.
External Validation of the Simplified Preoperative Assessment for Low-Grade Mucinous Adenocarcinoma of the Appendix.
Ann Surg Oncol
; 24(7): 1783-1786, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28315061
14.
ASO Author Reflections: The Frailty of Patient Selection.
Ann Surg Oncol
; 28(8): 4667, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33398643
15.
The 7th Edition of the AJCC Staging Classification Correlates with Biologic Behavior of Mucinous Appendiceal Tumor with Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC).
Ann Surg Oncol
; 23(6): 1928-33, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26714951
16.
ASO Author Reflections: When Laboratories Could Help Avoid Unnecessary Surgery.
Ann Surg Oncol
; 27(7): 2557-2558, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32189168
17.
Morbidity of the abdominal wall resection and reconstruction after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC).
Ann Surg Oncol
; 22(5): 1658-63, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25245127
18.
Port-site metastases is an independent prognostic factor in patients with peritoneal carcinomatosis.
Ann Surg Oncol
; 22(4): 1267-73, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25319578
19.
Melphalan: a promising agent in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Ann Surg Oncol
; 21(3): 908-14, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24276642
20.
Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
Ann Surg Oncol
; 21(13): 4218-25, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24986239